Some of the initial movement is water weight as the body depletes glycogen stores in response to reduced calorie intake
Daily oral orforglipron, a nonpeptide GLP-1 receptor agonist, was associated with weight reduction [30] [31], offering potential advantages regarding administration route and patient convenience
Learn more in our article Is Ozempic the Same as Semaglutide
The Needle-Averse Market is Massive A survey of over 1,000 adults living with obesity found that 71% would prefer a daily pill over a weekly injection when choosing a prescription weight-loss medication
Set realistic expectations around when patients will see results, how long they might need therapy, and what role lifestyle changes still play
If you need to lose 5 to 10 percent, a tablet may be enough